• Male/female subject aged ≥19 years inclusive at the time of informed consent.

• Clinical diagnosis of type 2 diabetes and DKD.

• 18.5 kg/m² \< body mass index \< 35 kg/m².

• Stable UACR values prior to screening visit.

• UACR between 200 and 3000 mg/g.

• Hemoglobin A1c ≤10% at Screening Visit.

• Subject who has been taking unchanged dosage of angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blockers (ARB) medication.

• Subject who has been on stable anti-hyperglycemic prior to screening.

• Females of childbearing potential/sexually active males with a partner of childbearing potential: commitment to consistently and correctly use an acceptable method of birth control.

⁃ Willing to be under dietary management for diabetes.

⁃ Willing to comply with all study procedures and availability for the duration of the study.

⁃ Capable of understanding the content of and able voluntarily to provide a signed and dated written informed consent form (ICF) prior to any study procedures.